Authors/Disclosures
|
Yessar M. Hussain, MD
(Austin Neuromuscular Center)
|
The institution of Dr. Hussain has received research support from Alnylam Pharma. |
|
Shibani S. Mukerji, MD, PhD
(Massachusetts General Hospital)
|
Dr. Mukerji has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. Dr. Mukerji has or had stock in Gilead Science.Dr. Mukerji has or had stock in Ranpack.Dr. Mukerji has or had stock in Snowflake. An immediate family member of Dr. Mukerji has or had stock in Amgen. The institution of Dr. Mukerji has received research support from NIH. The institution of Dr. Mukerji has received research support from Massachusetts General Hospital. |
|
Terrence M. Li, MD, FAAN
(Boston Medical Center - Brighton)
|
No disclosure on file |
|
|
No disclosure on file |
|
Barry M. Czeisler, MD, MS, MHPE, FAAN
(Providence Specialty Medical Group)
|
Dr. Czeisler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeuroStat Consulting LLC. Dr. Czeisler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for NeuroStat Consulting LLC. Dr. Czeisler has stock in Brainspace. Dr. Czeisler has received publishing royalties from a publication relating to health care. |